These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 29540482)

  • 1. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myristoylation-Dependent Palmitoylation of the Receptor Tyrosine Kinase Adaptor FRS2α.
    Barylko B; Chen YJ; Hennen J; Angert I; Chen Y; Mueller JD; Sun HQ; Taylor CA; Liou J; Yin H; Albanesi JP
    Biochemistry; 2019 Jun; 58(25):2809-2813. PubMed ID: 31184863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases.
    Fafilek B; Balek L; Bosakova MK; Varecha M; Nita A; Gregor T; Gudernova I; Krenova J; Ghosh S; Piskacek M; Jonatova L; Cernohorsky NH; Zieba JT; Kostas M; Haugsten EM; Wesche J; Erneux C; Trantirek L; Krakow D; Krejci P
    Sci Signal; 2018 Sep; 11(548):. PubMed ID: 30228226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
    Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
    Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
    Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
    Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3.
    Agazie YM; Movilla N; Ischenko I; Hayman MJ
    Oncogene; 2003 Oct; 22(44):6909-18. PubMed ID: 14534538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors.
    Lax I; Wong A; Lamothe B; Lee A; Frost A; Hawes J; Schlessinger J
    Mol Cell; 2002 Oct; 10(4):709-19. PubMed ID: 12419216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.
    Zhang Y; McKeehan K; Lin Y; Zhang J; Wang F
    Mol Endocrinol; 2008 Jan; 22(1):167-75. PubMed ID: 17901128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ternary complex formation of EphA4, FGFR and FRS2α plays an important role in the proliferation of embryonic neural stem/progenitor cells.
    Sawada T; Jing X; Zhang Y; Shimada E; Yokote H; Miyajima M; Sakaguchi K
    Genes Cells; 2010 Mar; 15(3):297-311. PubMed ID: 20184660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
    Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis.
    Zhang Y; Zhang J; Lin Y; Lan Y; Lin C; Xuan JW; Shen MM; McKeehan WL; Greenberg NM; Wang F
    Development; 2008 Feb; 135(4):775-84. PubMed ID: 18184727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.
    Kovalenko D; Yang X; Nadeau RJ; Harkins LK; Friesel R
    J Biol Chem; 2003 Apr; 278(16):14087-91. PubMed ID: 12604616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades.
    Hoshi T; Watanabe Miyano S; Watanabe H; Sonobe RMK; Seki Y; Ohta E; Nomoto K; Matsui J; Funahashi Y
    Biochem Biophys Res Commun; 2019 May; 513(1):1-7. PubMed ID: 30944079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway.
    Zhou W; Feng X; Wu Y; Benge J; Zhang Z; Chen Z
    Cell Res; 2009 Oct; 19(10):1165-77. PubMed ID: 19652666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.
    Liu J; You P; Chen G; Fu X; Zeng X; Wang C; Huang Y; An L; Wan X; Navone N; Wu CL; McKeehan WL; Zhang Z; Zhong W; Wang F
    Oncogene; 2016 Apr; 35(14):1750-9. PubMed ID: 26096936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.